Can molecular methods detect 1% isoniazid resistance in mycobacterium tuberculosis?

Journal of Clinical Microbiology

Volumn 51, Issue 5, 2013, Pages 1596-1599

  Folkvardsen, Dorte Bek ^a   Svensson, Erik ^a   Thomsen, Vibeke Ø ^a,e   Rasmussen, Erik Michael ^a   Bang, Didi ^a   Werngren, Jim ^b   Hoffner, Sven ^b   Hillemann, Doris ^c   Rigouts, Leen ^d  

^a STATENS SERUM INSTITUT   (Denmark)

^b Swedish Institute for Communicable Disease Control   (Sweden)

^c RESEARCH CENTER BORSTEL   (Germany)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e Danish Health and Medicines Authority   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; ISONIAZID; BACTERIAL PROTEIN; CATALASE; INHA PROTEIN, MYCOBACTERIUM; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASE; TUBERCULOSTATIC AGENT;

ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; CULTURE MEDIUM; GENOTYPE; INCUBATION TIME; INTERMETHOD COMPARISON; LINE PROBE ASSAY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CATALASE; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84876778117     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00472-13     Document Type: Article

References (10)

1. David HL. 1970. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl. Microbiol. 20:810-814.
2. Vilchèze C, Jacobs WR, Jr. 2007. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu. Rev. Microbiol. 61:35-50.
3. Canetti G, Froman S, Grosset J, Hauduroy P, Langerová M, Mahler HT, Meissner G, Mitchison DA, Šula L. 1963. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull. World Health Organ. 29:565-578.
4. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, Rist N, Šmelev NA. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis programmes. Bull. World Health Organ. 41:21-43.
5. Vijdea R, Stegger M, Sosnovskaja A, Andersen AB, Thomsen VØ, Bang D. 2008. Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolates. Eur. J. Clin. Microbiol. Infect. Dis. 27:1079-1086.
6. Migliori GB, Zellweger JP, Abubakar I, Ibraim E, Caminero JA, De Vries G, D'Ambrosio L, Centis R, Sotgiu G, Menegale O, Kliiman K, Aksamit T, Cirillo DM, Danilovits M, Dara M, Dheda K, Dinh-Xuan AT, Kluge H, Lange C, Leimane V, Loddenkemper R, Nicod LP, Raviglione MC, Spanevello A, Thomsen VØ Villar M, Wanlin M, Wedzicha JA, Zumla A, Blasi F, Huitric E, Sandgren A, Manissero D. 2012. European Union standards for tuberculosis care. Eur. Respir. J. 39: 807-819.
7. Abate G, Hoffner SE, Thomsen VO, Miörner H. 2001. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur. J. Clin. Microbiol. Infect. Dis. 20:329-333.
8. Palaci M, Ueki SYM, Sato DN, Telles MAS, Curcio M, Silva EAM. 1996. Evaluation of Mycobacteria Growth Indicator Tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens. J. Clin. Microbiol. 34:762-764.
9. Heym B, Honoré N, Truffot-Pernot C, Banerjee A, Schurra C, Jacobs WR, Jr, van Embden JD, Grosset JH, Cole ST. 1994. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 344:293-298.
10. Lindström A, Odeberg J, Albert J. 2004. Pyrosequencing for detection of lamivudine-resistant hepatitis B virus. J. Clin. Microbiol. 42:4788-4795.